- Home
- DCGO vs ESPR Comparison
DCGO vs ESPR Comparison
Compare DCGO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- ESPR
- Stock Information
- Founded
- DCGO 2015
- ESPR 2008
- Country
- DCGO United States
- ESPR United States
- Employees
- DCGO N/A
- ESPR N/A
- Industry
- DCGO Managed Health Care
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- DCGO Health Care
- ESPR Health Care
- Exchange
- DCGO Nasdaq
- ESPR Nasdaq
- Market Cap
- DCGO 272.3M
- ESPR 305.0M
- IPO Year
- DCGO N/A
- ESPR 2013
- Fundamental
- Price
- DCGO $2.64
- ESPR $1.50
- Analyst Decision
- DCGO Strong Buy
- ESPR Buy
- Analyst Count
- DCGO 5
- ESPR 7
- Target Price
- DCGO $5.30
- ESPR $6.36
- AVG Volume (30 Days)
- DCGO 985.6K
- ESPR 4.6M
- Earning Date
- DCGO 05-07-2025
- ESPR 03-04-2025
- Dividend Yield
- DCGO N/A
- ESPR N/A
- EPS Growth
- DCGO 200.00
- ESPR N/A
- EPS
- DCGO 0.18
- ESPR N/A
- Revenue
- DCGO $616,555,132.00
- ESPR $332,314,000.00
- Revenue This Year
- DCGO N/A
- ESPR $5.51
- Revenue Next Year
- DCGO $7.65
- ESPR $1.42
- P/E Ratio
- DCGO $14.75
- ESPR N/A
- Revenue Growth
- DCGO N/A
- ESPR 185.66
- 52 Week Low
- DCGO $2.63
- ESPR $1.47
- 52 Week High
- DCGO $5.68
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- DCGO 28.36
- ESPR 38.66
- Support Level
- DCGO $2.63
- ESPR $1.47
- Resistance Level
- DCGO $2.86
- ESPR $1.75
- Average True Range (ATR)
- DCGO 0.14
- ESPR 0.10
- MACD
- DCGO 0.05
- ESPR 0.01
- Stochastic Oscillator
- DCGO 2.22
- ESPR 10.71
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.